Literature DB >> 12512868

Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens.

Kevin S McDorman1, Douglas C Wolf.   

Abstract

The kidney is a frequent site for chemically induced cancers in rodents and among the 10 most frequent sites for cancer in human patients. Renal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80-85% of malignant renal tumors. Hereditary RCC occurs in Eker rats that are heterozygous for an insertion mutation in the Tsc2 tumor suppressor gene. The germline mutation renders heterozygous mutants highly susceptible to renal carcinogens. The utility of this model in studying potential renal carcinogens is due to an ordered progression of proliferative renal lesions that can be identified and counted microscopically. The quantitative nature of the model allows for the production of statistically powerful data to understand the relative degree and potency of chemical effects and allow analysis of genetic alterations that may be chemical specific.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512868     DOI: 10.1080/01926230290168542

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  10 in total

1.  Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin.

Authors:  Samy L Habib; Anamika Yadav; Lenin Mahimainathan; Anthony J Valente
Journal:  Genes Cancer       Date:  2011-11

2.  Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells.

Authors:  Samy L Habib; Besant K Bhandari; Nahed Sadek; Sherry L Abboud-Werner; Hanna E Abboud
Journal:  Carcinogenesis       Date:  2010-09-13       Impact factor: 4.944

3.  Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response.

Authors:  George R Schade; Yak-Nam Wang; Samantha D'Andrea; Joo Ha Hwang; W Conrad Liles; Tatiana D Khokhlova
Journal:  Ultrasound Med Biol       Date:  2018-10-16       Impact factor: 2.998

4.  Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors.

Authors:  Samy L Habib; Simona Simone; Jeff J Barnes; Hanna E Abboud
Journal:  Mol Cancer       Date:  2008-01-24       Impact factor: 27.401

5.  Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.

Authors:  Haruna Kawano; Yoshitaka Ito; Fumio Kanai; Eri Nakamura; Norihiro Tada; Setsuo Takai; Shigeo Horie; Toshiyuki Kobayashi; Okio Hino
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

6.  Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis.

Authors:  Arkadiusz D Liśkiewicz; Daniela Kasprowska; Anna Wojakowska; Krzysztof Polański; Joanna Lewin-Kowalik; Katarzyna Kotulska; Halina Jędrzejowska-Szypułka
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

7.  Revealing a Pre-neoplastic Renal Tubular Lesion by p-S6 Protein Immunohistochemistry after Rat Exposure to Aristolochic Acid.

Authors:  Alexandra Gruia; Patrycja Gazinska; Diana Herman; Valentin Ordodi; Calin Tatu; Peter Mantle
Journal:  J Kidney Cancer VHL       Date:  2015-09-08

Review 8.  Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers.

Authors:  Die Qian; Lisha He; Qing Zhang; Wenqing Li; Dandan Tang; Chunjie Wu; Fei Yang; Ke Li; Hong Zhang
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

9.  Molecular mechanism of regulation of OGG1: tuberin deficiency results in cytoplasmic redistribution of transcriptional factor NF-YA.

Authors:  Samy L Habib
Journal:  J Mol Signal       Date:  2009-12-29

10.  Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Authors:  Patrycja Gazinska; Diana Herman; Cheryl Gillett; Sarah Pinder; Peter Mantle
Journal:  Toxins (Basel)       Date:  2012-09-11       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.